Adenovir Pharma AB was founded in 2008 by the innovators, P.U.L.S. AB and its partners and investors. PULS has remained the largest owner of the comany.
PULS is a life science company with a unique combination of scientists and industrialists who together with innovators are commercializing ideas by providing capital, know-how and committed partnership, www.pulsinvest.se.
PULS has five active portfolio companies: Adenovir Pharma (eye infection), Belina Pharma (breast cancer), Glactone Pharma (immuno-oncology), Oncorena (renal cancer) and Trophea (skin atrophy).
|Company name:||Adenovir Pharma AB|
|Swedish corporate identity number:||556745-9986|
|Founded/Board:||Helsingborg, Sweden, in 2008|